Law360 has published an article by contributing editors here at Big Molecule Watch. The article, titled “IPR Estoppel Takes Shape,” looks at recent cases that discuss the scope of estoppel stemming from inter partes review proceedings. Click here for a link to the article.
Related Content
- Big Molecule WatchOctober 18, 2024
Teva’s Denosumab Biosimilar Candidate is Accepted for Review by FDA and EMA
- Big Molecule WatchOctober 16, 2024
Teva and mAbxience Add Additional Oncology Biosimilar Candidate, Expanding Strategic Partnership
- Big Molecule WatchOctober 14, 2024
Amgen Files BPCIA Complaint Against Fresenius Kabi Regarding Denosumab
- Big Molecule WatchOctober 7, 2024
PTAB Institutes Eight More IPRs Filed by Merck on Johns Hopkins Pembrolizumab Patents
- Big Molecule WatchOctober 5, 2024
Fresenius and Formycon Receive EC and FDA Approval of Ustekinumab Biosimilar
- Big Molecule WatchOctober 4, 2024
Aflibercept Biosimilar Updates in Europe
- Big Molecule WatchOctober 3, 2024
Express Scripts Sues FTC Over Report on Pharmacy Benefit Management Industry
- Big Molecule WatchSeptember 27, 2024
Recent Biosimilar Approvals By the FDA
- Awards and RankingsSeptember 9, 2024
Goodwin Named Venture Capital Firm of the Year, Hatch-Waxman Litigation Firm of the Year and Life Cycle Firm of the Year at the 2024 LMG Life Sciences Americas Awards
- Awards and RankingsSeptember 25, 2023
Goodwin Named an LMG Life Sciences Life Cycle Firm for the Twelfth Consecutive Year
- Awards and RankingsOctober 4, 2022
LMG Recognizes Goodwin Lawyers and Practices for Excellence in Life Sciences
- Press ReleaseNovember 17, 2021
Goodwin Releases Update to its Comprehensive Guide to Biosimilars Litigation and Regulation in the U.S.
- Awards and RankingsOctober 26, 2021
Goodwin Named an LMG Life Sciences Life Cycle Firm for the Tenth Consecutive Year
- Press ReleaseJune 28, 2021
Goodwin Adds Life Sciences and Healthcare Litigation Partner William Jackson
- EventsDecember 5, 2020
China's Patent Linkage System: Can Strategies that Work in the U.S. System Be Applied to China?
- Awards and RankingsOctober 5, 2020
Goodwin Named An LMG Life Sciences Life Cycle Firm For The Ninth Consecutive Year